C([O:5][C:6](=[O:32])[C:7]([CH3:31])([NH:9][C:10]([C:12]1[CH:20]=[CH:19][C:15]2[S:16][CH:17]=[CH:18][C:14]=2[C:13]=1[O:21][CH2:22]COC1C=CC=CC=1)=[O:11])[CH3:8])(C)(C)C.[F:33][C:34]([F:39])([F:38])[C:35](O)=O>ClCCl>[CH3:8][C:7]([NH:9][C:10]([C:12]1[CH:20]=[CH:19][C:15]2[S:16][CH:17]=[CH:18][C:14]=2[C:13]=1[O:21][CH2:22][C:12]1[CH:20]=[CH:19][C:35]([C:34]([F:39])([F:38])[F:33])=[CH:14][CH:13]=1)=[O:11])([CH3:31])[C:6]([OH:5])=[O:32]113 mg of 2-Methyl-2-{[4-(2-phenoxy-ethoxy)-benzo[b]thiophene-5-carbonyl]-amino}-propionic acid tert-butyl ester were dissolved in 2 ml dichloromethane and treated with 1 ml trifluoroacetic acid. After 6h at room temperature the volatiles were evaporated. The residue was treated with ethanol and 2 M HCl and evaporated three times. The resulting residue was crystallized from diethylether/heptane to afford 50 mg of 2-Methyl-2-{[4-(4-trifluoromethyl-benzyloxy)-benzo[b]thiophene-5-carbonyl]-amino}-propionic acid.